These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27913140)

  • 1. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.
    Kovalova N; Nault R; Crawford R; Zacharewski TR; Kaminski NE
    Toxicol Appl Pharmacol; 2017 Feb; 316():95-106. PubMed ID: 27913140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells.
    Lu H; Crawford RB; Suarez-Martinez JE; Kaplan BL; Kaminski NE
    Toxicol Sci; 2010 Nov; 118(1):86-97. PubMed ID: 20702590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
    Sulentic CE; Holsapple MP; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells.
    Kovalova N; Manzan M; Crawford R; Kaminski N
    Toxicol Appl Pharmacol; 2016 Oct; 309():15-23. PubMed ID: 27535091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
    Sulentic CE; Holsapple MP; Kaminski NE
    J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological characterization of the aryl hydrocarbon receptor (AHR) knockout rat in the presence and absence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Phadnis-Moghe AS; Chen W; Li J; Crawford RB; Bach A; D'Ingillo S; Kovalova N; Suarez-Martinez JE; Kaplan BL; Harrill JA; Budinsky R; Rowlands JC; Thomas RS; Kaminski NE
    Toxicology; 2016 Aug; 368-369():172-182. PubMed ID: 27590929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis.
    Li J; Phadnis-Moghe AS; Crawford RB; Kaminski NE
    Toxicology; 2017 Mar; 378():17-24. PubMed ID: 28049042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced CYP1A1 gene expression profile in lymphocytes from mice, rats, and humans: most potent induction in humans.
    Nohara K; Ao K; Miyamoto Y; Ito T; Suzuki T; Toyoshiba H; Tohyama C
    Toxicology; 2006 Aug; 225(2-3):204-13. PubMed ID: 16839655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of dioxin-altered mRNA expression in livers of dioxin-sensitive versus dioxin-resistant rats.
    Franc MA; Moffat ID; Boutros PC; Tuomisto JT; Tuomisto J; Pohjanvirta R; Okey AB
    Arch Toxicol; 2008 Nov; 82(11):809-30. PubMed ID: 18465118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of temporal and dose-dependent TCDD-elicited gene expression in human, mouse, and rat primary hepatocytes.
    Forgacs AL; Dere E; Angrish MM; Zacharewski TR
    Toxicol Sci; 2013 May; 133(1):54-66. PubMed ID: 23418086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone resorption by aryl hydrocarbon receptor-expressing osteoclasts is not disturbed by TCDD in short-term cultures.
    Ilvesaro J; Pohjanvirta R; Tuomisto J; Viluksela M; Tuukkanen J
    Life Sci; 2005 Aug; 77(12):1351-66. PubMed ID: 15913656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines.
    Son DS; Rozman KK
    Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene regulation by the human and mouse aryl hydrocarbon receptor.
    Flaveny CA; Murray IA; Perdew GH
    Toxicol Sci; 2010 Apr; 114(2):217-25. PubMed ID: 20044593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative toxicoproteogenomics of mouse and rat liver identifies TCDD-resistance genes.
    Prokopec SD; Lu A; Lee SCS; Yao CQ; Sun RX; Watson JD; Soliymani R; de Borja R; Wong A; Sam M; Zuzarte P; McPherson JD; Okey AB; Pohjanvirta R; Boutros PC
    Arch Toxicol; 2019 Oct; 93(10):2961-2978. PubMed ID: 31511937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.
    De Abrew KN; Kaminski NE; Thomas RS
    Toxicol Sci; 2010 Dec; 118(2):454-69. PubMed ID: 20819909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin elicits aryl hydrocarbon receptor-mediated apoptosis in the avian DT40 pre-B-cell line through activation of caspases 9 and 3.
    Puebla-Osorio N; Ramos KS; Falahatpisheh MH; Smith R; Berghman LR
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Aug; 138(4):461-8. PubMed ID: 15536054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
    Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
    Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Sulentic CE; Kaminski NE
    Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S171-91. PubMed ID: 20952503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
    Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.
    Kerkvliet NI; Shepherd DM; Baecher-Steppan L
    Toxicol Appl Pharmacol; 2002 Dec; 185(2):146-52. PubMed ID: 12490139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.